Ulcerative Colitis Forecast in 12 Major Markets 2017-2027: USA, Canada, France, Germany, Italy, Spain, UK, Russia, Brazil, Japan, China, India - Research and Markets

DUBLIN--()--The "Ulcerative Colitis Forecast in 12 Major Markets 2017-2027" report has been added to Research and Markets' offering.

This report provides the current prevalent population for Ulcerative Colitis across 12 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Russia, Brazil, Japan, China, India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight, several of the main symptoms and co-morbidities of Ulcerative Colitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Ulcerative Colitis include:

  • Anaemia
  • Gastritis
  • Colorectal cancer
  • Osteoporosis
  • Complications from surgery
  • Pouchitis
  • Toxic megacolon
  • Extra-intestinal features (e.g. primary sclerosing cholangitis, erythema nodosum)

Key Topics Covered:

  1. Introduction
  2. Cause of the Disease
  3. Risk Factors & Prevention
  4. Diagnosis of the Disease
  5. Variation by Geography/Ethnicity
  6. Disease Prognosis & Clinical Course
  7. Key Comorbid Conditions / Features Associated With the Disease
  8. Methodology for Quantification of Patient Numbers
  9. Top-Line Prevalence for Ulcerative Colitis
  10. Features of Ulcerative Colitis Patients
  11. Associated Conditions of Ulcerative Colitis
  12. Abbreviations Used in the Report
  13. Other Publications
  14. Online Patient-Based Databases
  15. Patient-Based Offering
  16. Online Pricing Data & Platforms
  17. References
  18. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/2g29rd/ulcerative

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Gastrointestinal Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Gastrointestinal Drugs